Picture of Phaxiam Therapeutics SA logo

PHXM — Phaxiam Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Erytech Pharma SA Reports Cash Position Of EUR 58.6 Million At End Of Q1 2020

May 6 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH PHARMA SA - CASH POSITION OF EUR 58.6 MILLION
($64.6
MILLION) AT END OF Q1 2020
    * ERYTECH PHARMA SA - INTERIM SUPERIORITY ANALYSIS FOR
TRYBECA-1
PHASE 3 TRIAL EXPECTED AROUND YEAR-END AND FINAL ANALYSIS IN 2H
OF 2021

Source text for Eikon:  ID:nGNX8Vk7wP 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phaxiam Therapeutics SA

See all news